2024 annual financial data
Enliven Therapeutics 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -104.55M USD and net income was -89.02M USD.
Operating cash flow was -73.19M USD.
Get free Enliven Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -104.55M USD
- Net income
- -89.02M USD
- Operating cash flow
- -73.19M USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Enliven Therapeutics financial years